Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, Trident Lifeline has informed that a meeting of the Board of Directors of the company will be held on Monday, 28th July, 2025 to for the following business: 1. To consider, approve and take on record the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30th June, 2025; 2. Any other items with the permission of the chairman. Further, Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, read with Code of Conduct Framed by the Company and in continuation to its letter dated 28th June, 2025, the Trading Window for trading in the Company’s equity shares was closed from 01st July 2025 and shall reopen 48 hours after the results of the meeting are made public on 28th July, 2025.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1696.65 |
| Dr. Reddys Lab | 1218.30 |
| Cipla | 1226.65 |
| Zydus Lifesciences | 936.00 |
| Lupin | 2339.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: